Search - tctmd.com

Displaying 421 - 440 of 861

Sort: Relevancy | Date

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

There Is Hope for Producing Preclinical Models for Successful Device Development

Presenter: Gregory J. Wilson

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

News Daily News

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

L.A. McKeown

September 13, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Conference News ESC 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Yael L. Maxwell

September 03, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Conference News ESC 2014

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

News Industry News

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

August 27, 2014

News Daily News

Radial-to-Femoral Crossover Results in Minimal Delay, Has Little Impact on STEMI Outcomes

Yael L. Maxwell

August 20, 2014

News Daily News

CLOSURE I Analysis Suggests Many Recurrent Strokes Are Unrelated to PFO

August 20, 2014

News Daily News

Angina Tops Ischemia as Predictor of Stable CAD Outcomes

Todd Neale

August 20, 2014

News Daily News

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

Yael L. Maxwell

August 07, 2014

News Daily News

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Todd Neale

August 07, 2014

Advertisement

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

There Is Hope for Producing Preclinical Models for Successful Device Development

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Renal Nerve Microanatomy - The Foundation for RDN Technologies

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Post-Acute MI Survival Improving for Elderly Patients in France

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

Radial-to-Femoral Crossover Results in Minimal Delay, Has Little Impact on STEMI Outcomes

CLOSURE I Analysis Suggests Many Recurrent Strokes Are Unrelated to PFO

Angina Tops Ischemia as Predictor of Stable CAD Outcomes

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content